Navigation Links
2009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60% Despite Current Recession

LONG BRANCH, N.J., June 3 /PRNewswire/ -- The 2009 Pharma ChemOutsourcing Conference & Exhibition attendance is way up again in 2009 and is poised to shatter the attendance record set in 2008. The remarkable success of last year's meeting generated the positive buzz responsible for much of the growth. Attendance for the September 14-16, 2009 event is expected to be about 1000.

Also attracting high attendance is the conference program newly focused on the outsourcing needs of small molecule biotech companies, today's drivers behind much of the growth of the pharmaceutical industry, reports Mark Alexay of Apaporis LLC, the organizer. In 2009, 35 different biotech company chemists are participating as speakers.

The high interest in the new biotech track offers biotech company process and medicinal chemistry, supply chain and manufacturing management personnel opportunity to share their chemical sourcing experiences and strategies. Given the small size of most of the firms, the 35 speakers provide a rare glimpse into the challenges they face to secure external suppliers to do their scale up manufacturing. The track may be viewed at

Biotech participants include speakers from King Pharmaceuticals, Medivation, GPC Biotech, Theravance, Bionumerik Pharmaceuticals, Anthera Pharmaceuticals, Palatin Technologies, Magen Biosciences, Inspire Pharmaceuticals, Geron Pharmaceuticals, Phenomix Corporation and CoNCERT Pharmaceuticals.

The show will take place at the beachfront Ocean Place Resort in Long Branch, NJ. The high end venue affords beach area for nightly barbecues and parties to facilitate informal networking. The show kicks off on Sunday, September 13 and ends Wednesday, September 16.

Additional speakers include BioMarin Pharmaceuticals, Array BioPharma, Reata Pharmaceuticals, Proteolix, Novalar Pharmaceuticals, Lexicon Pharmaceuticals, Orexigen Therapeutics, Targacept, Helsinn Therapeutics, OSI Prosidion, NovaDel Pharma, Anacor Pharmaceuticals, Ceragenix, Millennium Pharmaceuticals (Takeda), Pharmasset, Oscient Pharmaceuticals, Cenomed Biosciences, Alkermes, Epix Pharmaceuticals, and Ardea Biosciences.

The exhibit area is strictly limited to 100 booths and is nearly full 3 1/2 months before the show. The list and exhibitor profiles may be viewed at

For more information about Pharma ChemOutsourcing and to view the 120-speaker conference or attendee list at or contact Mark Alexay at or 201.452.4023.

Pharma ChemOutsourcing is organized by Apaporis LLC.

Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
5. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
Post Your Comments:
(Date:11/27/2015)... , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: ... today that it has closed the sale of its ... Guerbet (GBT- NYSE Euronext) in a transaction valued at ... manufacturing facilities and a total of approximately 1,000 employees ... St. Louis area. This entire ...
(Date:11/26/2015)... England , November 26, 2015 ... medical device company specializing in imaging technologies, announced today that ... Commission as part of the Horizon 2020 European Union Framework ... out a large-scale clinical trial in breast cancer. ... , --> --> ...
(Date:11/25/2015)... 25, 2015 Studies reveal the ... plaque and pave the way for more effective treatment for ...     --> --> ... health problems in cats, yet relatively little was understood about ... studies have been conducted by researchers from the WALTHAM Centre ...
(Date:11/25/2015)... ... 25, 2015 , ... A long-standing partnership between the Academy ... been formalized with the signing of a Memorandum of Understanding. , AMA Executive ... Karl Minter and Capt. Albert Glenn Tuesday, November 24, 2015, at AMA Headquarters ...
Breaking Biology Technology:
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
(Date:10/29/2015)... RESTON, Va. , Oct. 29, 2015 ... announced today that it has released a new version ... Daon customers in North America ... gains. IdentityX v4.0 also includes a FIDO UAF ... customers are already preparing to activate FIDO features. These ...
(Date:10/29/2015)... 29, 2015 NXTD ) ... focused on the growing mobile commerce market and ... StackCommerce, a leading marketplace to discover and buy ... smart wallet on StackSocial for this holiday season. ... the "Company"), a biometric authentication company focused on ...
Breaking Biology News(10 mins):